Worg Biotherapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Worg Biotherapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz (NCT06240455) | Worg Biotherapeutics Inc. | 2026-03-31 |
Track Worg Biotherapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.